Catalog
Research Peptides
>99% purity · Janoshik-verified · EU / USA / UK
GHK-Cu
Copper tripeptide for collagen + skin.
View compound →TB-500
Thymosin β-4 for accelerated repair.
View compound →GLP-1 RC-R
GLP-1 / GIP / Glucagon triple agonist.
View compound →BPC-157
Gold-standard regenerative peptide.
View compound →Melanotan II
α-MSH analogue for pigmentation.
View compound →No products match
Try a different category or .
Research Compounds
GHK-Cu
(Glycyl-L-Histidyl-L-Lysine Copper)
Reverses skin-aging markers and rebuilds the extracellular matrix, the most-studied peptide in cosmetic and tissue-regeneration research. The copper-binding tripeptide stimulates collagen and elastin synthesis, accelerates wound healing, activates antioxidant defences, and supports hair follicle regeneration.
TB-500
(Thymosin Beta-4 Fragment)
Drives systemic tissue repair across muscle, tendon, and ligament, the heavy hitter of connective-tissue research. As a synthetic thymosin beta-4 fragment, it promotes angiogenesis, dampens injury-site inflammation, and accelerates cell migration to damaged areas in published recovery studies.
GLP-1 RC-R
(GIP/GLP-1/Glucagon Triple Receptor Agonist)
Most potent metabolic compound in current trial data, superior weight reduction over single and dual agonists in head-to-head research. The triple agonist hits GLP-1, GIP, and glucagon receptors simultaneously, suppressing appetite, accelerating lipolysis, and improving glycaemic control.
BPC-157
(Body Protection Compound-157)
Accelerates gut, tendon, and joint repair across the body, the most cited cytoprotective peptide in regenerative research. Derived from a fragment of human gastric juice, it modulates systemic inflammation, supports nitric oxide pathways, and shows protective effects across the GI tract and vascular system.
Melanotan II
(Synthetic Alpha-Melanocyte Stimulating Hormone)
Drives skin tanning, UV photoprotection, and appetite suppression from a single compound, research applications span pigmentation, sexual function, and metabolic regulation. The synthetic α-MSH analogue activates melanocortin receptors and is also studied for libido enhancement via MC4R pathways.
Tesamorelin
(Stabilised GHRH 1-44 Analog)
Selectively reduces visceral abdominal fat, the strongest clinical data of any GHRH analogue, extensively studied for HIV-associated lipodystrophy. Stimulates pulsatile growth hormone release, improves IGF-1 and lipid profile, and shifts body composition without significant glucose impact.
Selank
(Synthetic Tuftsin Analog / TP-7)
Reduces anxiety without sedation, dependence, or cognitive impairment, a clean nootropic-anxiolytic for stress resilience, attention, and mood research. The Russian-developed heptapeptide boosts BDNF, balances enkephalin levels, and sharpens memory in extensively studied protocols.
Semax
(Synthetic ACTH 4-10 Analog)
Laser focus, mood lift, and neuroprotection, a Russian clinical staple for stroke recovery, ADHD, and cognitive enhancement research. The synthetic ACTH 4-10 analogue upregulates BDNF and NGF, enhances dopamine signalling, and protects against ischaemic injury.
MOTS-c
(Mitochondrial-Derived Peptide)
Mimics the effects of exercise at the metabolic level, improves insulin sensitivity, endurance, and metabolic flexibility. The mitochondrial-derived peptide activates AMPK and is the first endogenous mito-peptide in clinical human research, studied for diabetes, obesity, and longevity.
AOD-9604
(Advanced Obesity Drug, HGH Frag 177-191)
Drives stubborn adipose lipolysis with zero impact on blood sugar or IGF-1, a clean fat-loss tool across obesity research. The modified GH fragment 177-191 also supports cartilage repair via chondrocyte signalling and remains fully non-insulinogenic in joint-research models.
Sermorelin
(GHRH 1-29 / Growth Hormone-Releasing Factor)
Restores natural pulsatile growth hormone release without supraphysiological IGF-1 spikes, preferred for anti-aging research and gentler GH-axis support studies. The GHRH 1-29 fragment supports sleep depth, skin elasticity, energy, and recovery via the body's own physiological release pattern.
GLP-1 RC-S
(GLP-1 Receptor Agonist)
Drives steady, sustained weight loss with strong glycaemic control, the most extensively studied weight-management compound of the modern metabolic-research era. The GLP-1 receptor agonist suppresses appetite, slows gastric emptying, and regulates blood sugar via incretin signalling.
GLP-1 RC-T
(GIP/GLP-1 Dual Receptor Agonist)
Outperforms single-agonist GLP-1 RC-S for weight loss and insulin sensitisation, the dual GLP-1 / GIP receptor agonist redefining metabolic research. Combines appetite suppression with improved fat oxidation and lipid metabolism, delivering greater body-composition shifts in head-to-head trials.
Cagrilintide
(NN9838, Amylin analogue)
Suppresses appetite and food intake through pathways complementary to GLP-1, studied as a stand-alone weight-management compound and as a synergistic add-on to incretin therapies. The long-acting amylin analogue also slows gastric emptying for sustained satiety in metabolic research.
CJC-1295 DAC
(Modified GRF 1-29 with Drug Affinity Complex)
Sustained week-long GH and IGF-1 elevation, popular for long-acting GH-axis research with minimal injection frequency. The GHRH analogue uses a Drug Affinity Complex to extend half-life, supporting deeper sleep, fat loss, lean muscle, and recovery throughout each cycle.
Ipamorelin
(Selective GH-Releasing Pentapeptide)
Gold standard for low-side-effect growth hormone research, produces a clean GH pulse without raising cortisol, prolactin, or hunger. The selective ghrelin receptor agonist pairs excellently with GHRH analogues like CJC-1295 for synergistic GH release in layered protocols.
GHRP-2
(Pralmorelin, KP-102)
Workhorse of GH-secretagogue research with decades of clinical data, strong GH pulse with moderate appetite stimulation and mild cortisol/prolactin rise. The second-generation growth hormone releasing peptide supports lean mass accrual, recovery, and IGF-1 elevation across study protocols.
GHRP-6
(Growth Hormone Releasing Hexapeptide)
Potent ghrelin-mediated GH pulses with strong appetite stimulation, ideal for hard-gainer or bulking research protocols. The original GH-releasing hexapeptide is also studied for cardioprotective and tissue-repair effects beyond simple growth hormone release, making it a versatile GHRP research tool.
CJC-1295 (no DAC)
(Modified GRF 1-29, Mod GRF)
Tight pulse control for layered GH research stacks, a brief, natural pulsatile GH spike that mirrors physiological release. The short-acting GHRH analogue (Mod GRF 1-29) is preferred when researchers want pulse precision over the sustained week-long elevation of the DAC version.
Hexarelin
(Examorelin, MF-6003)
Most potent GHRP analogue with stronger GH pulses than GHRP-2 or GHRP-6, and uniquely cardioprotective. Documented cardiac-remodelling effects via CD36 receptor activity make it a dual-use tool for both growth hormone research and ischaemic heart-tissue protection in cardiovascular models.
PT-141
(Bremelanotide)
Enhances libido and sexual function in both men and women through CNS pathways, independent of testosterone or vascular mechanisms, and FDA-approved for HSDD. The melanocortin receptor agonist (Bremelanotide) is widely studied across sexual dysfunction research with extensive clinical data.
IGF-1 LR3
(Insulin-like Growth Factor-1 Long Arg3)
The heavy hitter for cell-growth and hyperplasia research, drives muscle hypertrophy, satellite cell activation, and tissue growth via sustained anabolic signalling. The Long Arg3 variant of IGF-1 has reduced binding-protein affinity and a half-life around 20-30 hours.
MGF
(Mechano Growth Factor, IGF-1Ec)
Site-specific muscle repair and hyperplasia at the injection point, activates satellite cells where mechanical strain occurs. The local IGF-1 splice variant has a short half-life that makes it ideal for targeted muscle research rather than systemic anabolism.
PEG-MGF
(PEGylated Mechano Growth Factor)
Whole-body muscle and recovery research with sustained circulation, reaches damaged tissue everywhere to activate satellite cells, drive repair, and support hyperplasia. PEGylation of mechano growth factor extends the systemic half-life so MGF's regenerative signalling stays in play across the body.
Epitalon
(Epithalon / Ala-Glu-Asp-Gly Tetrapeptide)
The most-studied longevity peptide, activates telomerase, lengthens telomeres, and resets circadian melatonin rhythms. The synthetic tetrapeptide modelled on the pineal hormone epithalamin has multi-decade Russian clinical data on aging biomarkers, sleep quality, and lifespan extension.
Cerebrolysin
(FPF 1070, Peptide complex)
The gold-standard neurorestorative research tool, 30+ years of clinical use across 50 countries for stroke, dementia, and traumatic brain injury. The porcine brain-derived peptide complex mimics endogenous neurotrophic factors to support neuronal survival, plasticity, and recovery.
5-Amino-1MQ
(5-Amino-1-methylquinolinium)
Reactivates NAD+ metabolism inside fat cells, restores metabolic flexibility and reduces adipocyte size in preclinical obesity research. The selective NNMT inhibitor is studied across insulin resistance and age-related metabolic decline, complementing broader NAD+ longevity research with strong adipose data.
FOXO4-DRI
(Senolytic peptide)
Clears the inflammatory senescent-cell load that drives biological aging, a flagship compound for rejuvenation research with strong rodent data on tissue revitalisation. The senolytic peptide selectively triggers apoptosis in senescent cells by disrupting the FOXO4-p53 interaction.
SNAP-8
(Acetyl Glutamyl Heptapeptide-3)
Softens expression lines without needles, paralysis, or systemic neurotoxin exposure, a topical alternative to botulinum research. The octapeptide analogue of SNAP-25 modulates neuromuscular junction signalling for non-invasive wrinkle-reduction research with extensive cosmetic data.
Thymosin Alpha-1
(Thymalfasin / Immune Modulator)
Supercharges adaptive immunity, boosts T-cell maturation, modulates cytokine balance, and enhances antiviral and antitumor response. The 28-amino acid thymic peptide is clinically used for hepatitis, sepsis, and immune-compromised states across 35+ countries with extensive immunology research data.
HCG
(Human Chorionic Gonadotropin)
Restores endogenous testosterone and prevents testicular atrophy in suppressive-cycle research, a foundational compound in HPG-axis, fertility, and reproductive endocrinology studies. The glycoprotein hormone mimics luteinising hormone to stimulate testicular Leydig cells and ovarian follicles.
KPV
(Lys-Pro-Val, α-MSH tripeptide)
Calms IBD-style gut inflammation and accelerates wound healing, without pigmentation or appetite effects. The C-terminal tripeptide of α-MSH retains anti-inflammatory and antimicrobial activity, inhibits mast-cell activation, and is studied across inflammatory, dermatological, allergic, and GI research applications.
LL-37
(Cathelicidin, CAMP peptide)
Frontline endogenous defence molecule, broad-spectrum activity against bacteria, viruses, and fungi, plus immunomodulation and wound-healing acceleration. The sole human cathelicidin antimicrobial peptide is studied as a research tool for antibiotic resistance, chronic infection, and innate immunity.
Melanotan-1
(Afamelanotide, Scenesse)
The most studied medical-grade tanning compound, clinically approved for erythropoietic protoporphyria-related phototoxicity, with both EMA and FDA approval. The linear α-MSH analogue (Afamelanotide) drives sustained eumelanin production for UV photoprotection without the appetite or libido effects of MTII.